MTV, sundhedstjenesteforskning og klinisk praksis
MTV, sundhedstjenesteforskning og klinisk praksis
MTV, sundhedstjenesteforskning og klinisk praksis
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Referencer<br />
1. Alban A et al Sundhedsøkonomiske analyser af lægemidler – en gennemgang af metoder <strong>og</strong><br />
problemstillinger ved implementering i beslutningsprocesser. København: Sundhedsstyrelsen;<br />
1995<br />
2. Alban A et al Sundhedsøkonomi. Principper <strong>og</strong> perspektiver. København: DSI•Institut for Sundhedsvæsen;<br />
1999. DSI-rapport; 99.01<br />
3. Drummond MF et al. Methods for the Economic Evaluation of Health Care Pr<strong>og</strong>rammes. Oxford:<br />
Oxford University Press, 1997<br />
4. Gold MR et al (eds). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press;<br />
1996<br />
5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:<br />
The Scandinavian Simvastatin Survival Study. Lancet 1994;344:1383-89<br />
6. Pedersen TR et al. Cholesterol Lowering and the Use of Healthcare Resources. Results from The<br />
Scandinavian Simvastatin Survival Study Circulation 1996; 93:1796-1802<br />
7. Jönsson B et al. Cost-effectiveness of cholesterol lowering. Results from The Scandinavian<br />
Simvastatin Survival Study (4S). Eur Heart J 1996;17:1001-07<br />
8. Johannesson M et al. Cost effectiveness of Simvastatin treatment to lower cholesterol levels in<br />
patients with coronary heart disease. N Engl J Med 1997;336:332-06<br />
9. Gyrd-Hansen D. Modelling the cost-effectiveness of cancer screening in Denmark. Applications<br />
and issues of methodol<strong>og</strong>y. Odense: Center for Helsetjenesteforskning <strong>og</strong> Socialpolitik, Odense<br />
Universitet; 1998. Afhandlinger fra det samfundsvidenskabelige fakultet på Odense Universitet;<br />
31<br />
10. Cromwell J et al. Cost-effectiveness of the Clinical Practice Recommendations in the AHCPR<br />
Guideline for Smoking Cessation. JAMA 1997;278:1759-1766<br />
11. Luce BR et al. Estimating Costs in Cost-Effectiveness Analysis. Kap 6 i Gold MR et al(eds).<br />
Cost-Effectiveness in Health and Medicin. New York: Oxford University Press;1996<br />
12. Alban A <strong>og</strong> Knudsen JL. Prioritering i sundhedsvæsenet. Økonomisk vurdering af behandlingen af<br />
de ekstremt små nyfødte i Danmark. København: Dansk Sygehus Institut; 1991. DSI-rapport 91.03<br />
13. Juhl HH. Samfundsøkonomisk evaluering af valget mellem regional <strong>og</strong> generel anæstesi ved total<br />
hoftealloplastik. Odense: Odense Universitetsforlag; 1992<br />
14. Kidholm K. Estimation af betalingsvilje for forebyggelse af personskader ved trafikulykker.<br />
Odense: Odense Universitet; 1995. Afhandlinger fra det samfundsvidenskabelige fakultet på<br />
Odense Universitet; 21<br />
15. Canadian Coordinating Office for Health Technol<strong>og</strong>y Assessment (CCOHTA). Guidelines for the<br />
pharmaceutical industry on preparation of pharmaceuticals. Canada. 2nd ed., Ottawa: CCOHTA;<br />
1997<br />
16. Commonwealth Department of Human Services and Health (CDHSH). Guidelines for the<br />
pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory<br />
Committee. Canberra: Australian Government Publishing Office; 1995<br />
74